Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for Intestinal Adenomas in FAP
NCT00641147Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2010
- Primary completion
- Nov 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in familial adenomatous polyposis (FAP) comparing Curcumin Arm with Placebo Arm (2 arms). Primary endpoint: Polyp Number at 12 months. Started Oct 2010; status: completed.
02
Drugs
curcumin
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT00641147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641147.